PCSM-02 SURVIVORSHIP CARE PLANNING IN THE NEURO-ONCOLOGY CLINIC

Autor Amidei, Christina, Arzbaecher, Jean, Nicholas, M. Kelly
Vydáno v Neuro Oncol (2015)

Targeted therapy in the treatment of malignant gliomas

Autor Lukas, Rimas V, Boire, Adrienne, Nicholas, M Kelly
Vydáno 2009

Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas

Autor Liang, Yu, Bollen, Andrew W, Nicholas, M Kelly, Gupta, Nalin
Vydáno 2005

PCSM-01 INTEGRATING PATIENT SELF-REPORT DATA INTO THE NEURO-ONCOLOGY CLINIC EXPERIENCE: LESSONS LEARNED

Autor Amidei, Christina, Frazier-Warmack, Victoria, Arzbaecher, Jean, Nicholas, M. Kelly
Vydáno v Neuro Oncol (2015)

EG-08 IDH MUTATIONS IN GLIOMAS ASSOCIATED WITH ENCHONDROMATOSIS

Autor Nicholas, M. Kelly, Joseph, Loren, Venneti, Sriram, Daher, Ahmad, Pytel, Peter
Vydáno 2014

TMOD-31. NOVEL GENETIC CHARACTERIZATION OF MURINE MEDULLOBLASTOMA CELL LINES

Autor Rumler, Sarah, Maienschein-Cline, Mark, Noronha, Melline Fontes, Song, Fei, Lock, Andrew, Loeb, Jeffrey, Nicholas, M Kelly
Vydáno v Neuro Oncol (2020)

A Phase I Study of Continuous Infusion Cilengitide in Patients with Solid Tumors

Autor O’Donnell, Peter H., Undevia, Samir D., Stadler, Walter M., Karrison, Theodore M., Nicholas, M. Kelly, Janisch, Linda, Ratain, Mark J.
Vydáno 2010

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

Autor Liang, Yu, Diehn, Maximilian, Watson, Nathan, Bollen, Andrew W., Aldape, Ken D., Nicholas, M. Kelly, Lamborn, Kathleen R., Berger, Mitchel S., Botstein, David, Brown, Patrick O., Israel, Mark A.
Vydáno 2005

Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme

Autor Larson, David A., Suplica, Jeffrey M., Chang, Susan M., Lamborn, Kathleen R., McDermott, Michael W., Sneed, Penny K., Prados, Michael D., Wara, William M., Nicholas, M. Kelly, Berger, Mitchel S.
Vydáno 2004

The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy

Autor Zhai, Lijie, Dey, Mahua, Lauing, Kristen L., Gritsina, Galina, Kaur, Rajwant, Lukas, Rimas V., Nicholas, M. Kelly, Rademaker, Alfred W., Dostal, Carlos R., McCusker, Robert H., Raizer, Jeffrey J., Parsa, Andrew T., Bloch, Orin, Wainwright, Derek A.
Vydáno v J Clin Neurosci (2015)

Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

Autor Prados, Michael D., Yung, W.K. Alfred, Fine, Howard A., Greenberg, Harry S., Junck, Larry, Chang, Susan M., Nicholas, M. Kelly, Robins, H. Ian, Mehta, Minesh P., Fink, Karen L., Jaeckle, Kurt A., Kuhn, John, Hess, Kenneth R., Schold, S. Clifford
Vydáno 2004

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study

Autor Prados, Michael D., Lamborn, Kathleen, Yung, W.K.A., Jaeckle, Kurt, Robins, H. Ian, Mehta, Minesh, Fine, Howard A., Wen, Patrick Y., Cloughesy, Timothy, Chang, Susan, Nicholas, M. Kelly, Schiff, David, Greenberg, Harry, Junck, Larry, Fink, Karen, Hess, Ken, Kuhn, John
Vydáno 2006

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study

Autor Prados, Michael D., Yung, W.K.A., Jaeckle, Kurt A., Robins, H. Ian, Mehta, Minesh P., Fine, Howard A., Wen, Patrick Y., Cloughesy, Timothy F., Chang, Susan M., Nicholas, M. Kelly, Schiff, David, Greenberg, Harry S., Junck, Larry, Fink, Karen L., Hess, Kenneth R., Kuhn, John
Vydáno 2004

Phase II Study of Fenretinide (NSC 374551) in Adults With Recurrent Malignant Gliomas: A North American Brain Tumor Consortium Study

Autor Puduvalli, Vinay K., Yung, W.K. Alfred, Hess, Kenneth R., Kuhn, John G., Groves, Morris D., Levin, Victor A., Zwiebel, James, Chang, Susan M., Cloughesy, Timothy F., Junck, Larry, Wen, Patrick, Lieberman, Frank, Conrad, Charles A., Gilbert, Mark R., Meyers, Christina A., Liu, Vivien, Mehta, Minesh P., Nicholas, M. Kelly, Prados, Michael
Vydáno 2004